Signet Therapeutics Company

Signet Therapeutics is a biopharmaceutical startup focusing on developing innovative targeted cancer drugs using novel disease models.

Last Funding Type: Seed
Funding Status: Seed
Headquarters: Newton, Massachusetts, United States
Founded Date: 2020-01-01
Last Funding Date: 2021-10-29
Total Funding: 20000000
Investors Number: 5
Industry: Early and Preclinical Drug Development